ELLICOTT CITY, Md., April 24, 2012 /PRNewswire/ -- Adam Chasse, RxTrials' vice president of Corporate Development, was inducted into Delta Omega, the public health honorary society, during ceremonies at the University of North Carolina at Chapel Hill (UNC-CH), on Friday, April 20.
Chasse earned a Master of Healthcare Administration degree in 2011 from the Gillings School of Global Public Health at UNC-CH. He has a long and distinguished career in clinical research, having served in various roles at international CRO Quintiles from 1995 until joining RxTrials last year. At RxTrials, he directs the organization's growth by increasing study volume and enhancing strategic relationships. Throughout his career, Chasse has been committed to improving quality and operational efficiency in clinical research in order to help new medicines get into the hands of the patients that need them.
The Delta Omega Honorary Society in Public Health was founded in 1924 to recognize outstanding achievement in the field of public health. As the scope of public health has broadened, Delta Omega expanded its reach while still recognizing its founding ideals. Today's members come from a broad spectrum of professions dedicated to public health.
"Inasmuch as membership in Delta Omega recognizes dedication to quality and advancement of good health for all, this is a proud personal achievement for me," Chasse said, "but just as importantly, those are the values my RxTrials colleagues and I strive to demonstrate for our patients and our clients every day. This honor reinforces that commitment."
RxTrials, Inc., is a network of premier clinical research sites that, through partnerships with more than 100 top study sponsors and CROs, has conducted more than 1,000 studies helping to bring new drugs, vaccines and medical devices to market. It also is the parent company of RxTrials Institute, a leading national clinical research consultant and education provider. Rx
|SOURCE RxTrials, Inc.|
Copyright©2010 PR Newswire.
All rights reserved